How would you treat a patient with stage I non muscle invasive urothelial bladder cancer with small cell/neuroendocrine features, Ki67 90%?   

Small-cell cancer of the bladder is a rare variant and highly aggressive disease with frequent and early systemic dissemination. Given an absence of controlled clinical trials (and likely that high level evidence may never be available), management is based on clinical judgment and is frequently ext...